BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sencio V, Gallerand A, Gomes Machado M, Deruyter L, Heumel S, Soulard D, Barthelemy J, Cuinat C, Vieira AT, Barthelemy A, Tavares LP, Guinamard R, Ivanov S, Grangette C, Teixeira MM, Foligné B, Wolowczuk I, Le Goffic R, Thomas M, Trottein F. Influenza Virus Infection Impairs the Gut's Barrier Properties and Favors Secondary Enteric Bacterial Infection through Reduced Production of Short-Chain Fatty Acids. Infect Immun 2021;89:e0073420. [PMID: 33820816 DOI: 10.1128/IAI.00734-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Raffatellu M, Bäumler AJ. Special Collection on the Microbiome and Infection. Infect Immun 2021;89:e0035621. [PMID: 34280036 DOI: 10.1128/IAI.00356-21] [Reference Citation Analysis]
2 Brun P, Conti J, Zatta V, Russo V, Scarpa M, Kotsafti A, Porzionato A, De Caro R, Scarpa M, Fassan M, Calistri A, Castagliuolo I. Persistent Herpes Simplex Virus Type 1 Infection of Enteric Neurons Triggers CD8+ T Cell Response and Gastrointestinal Neuromuscular Dysfunction. Front Cell Infect Microbiol 2021;11:615350. [PMID: 34094993 DOI: 10.3389/fcimb.2021.615350] [Reference Citation Analysis]
3 Verstraeten S, Sencio V, Raise A, Huillet E, Layec S, Deruyter L, Heumel S, Auger S, Robert V, Langella P, Beney L, Trottein F, Thomas M. Description of a Newly Isolated Blautia faecis Strain and Its Benefit in Mouse Models of Post-Influenza Secondary Enteric and Pulmonary Infections. Nutrients 2022;14:1478. [DOI: 10.3390/nu14071478] [Reference Citation Analysis]
4 Venzon M, Bernard-Raichon L, Klein J, Axelrad J, Hussey G, Sullivan A, Casanovas-Massana A, Noval M, Valero-Jimenez A, Gago J, Wilder E, Team YIR, Iwasaki A, Thorpe L, Littman D, Dittmann M, Stapleford K, Shopsin B, Torres V, Ko A, Cadwell K, Schluter J. Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocation. Res Sq 2021:rs. [PMID: 34341786 DOI: 10.21203/rs.3.rs-726620/v1] [Reference Citation Analysis]
5 Sencio V, Machelart A, Robil C, Benech N, Hoffmann E, Galbert C, Deryuter L, Heumel S, Hantute-Ghesquier A, Flourens A, Brodin P, Infanti F, Richard V, Dubuisson J, Grangette C, Sulpice T, Wolowczuk I, Pinet F, Prévot V, Belouzard S, Briand F, Duterque-Coquillaud M, Sokol H, Trottein F. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters. Gut Microbes 2022;14:2018900. [PMID: 34965194 DOI: 10.1080/19490976.2021.2018900] [Reference Citation Analysis]
6 Cruz CS, Ricci MF, Vieira AT. Gut Microbiota Modulation as a Potential Target for the Treatment of Lung Infections. Front Pharmacol 2021;12:724033. [PMID: 34557097 DOI: 10.3389/fphar.2021.724033] [Reference Citation Analysis]